GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 191 filers reported holding GENMAB A/S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,749 | +402.8% | 1,127 | +441.8% | 0.00% | – |
| Q2 2023 | $7,906 | +79.0% | 208 | +77.8% | 0.00% | – |
| Q1 2023 | $4,417 | -52.6% | 117 | -46.8% | 0.00% | – |
| Q4 2022 | $9,322 | +86.4% | 220 | +27.9% | 0.00% | – |
| Q3 2022 | $5,000 | -68.8% | 172 | -64.5% | 0.00% | -100.0% |
| Q2 2022 | $16,000 | -72.4% | 485 | -69.5% | 0.00% | -66.7% |
| Q1 2022 | $58,000 | +5.5% | 1,590 | +11.5% | 0.00% | +50.0% |
| Q4 2021 | $55,000 | -9.8% | 1,426 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $61,000 | +6000.0% | 1,412 | +3822.2% | 0.00% | – |
| Q2 2021 | $1,000 | – | 36 | +50.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 24 | -96.0% | 0.00% | -100.0% |
| Q2 2020 | $20,000 | +66.7% | 596 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $12,000 | – | 596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |